FDA Entry Point Services, Ideal-Fit Customers, and Pricing

Introduction

Buyers usually reach this page when they are trying to answer two practical questions at once: what FDA Entry Point actually handles, and whether the posted price is just for a mailbox-style U.S. Agent or for a broader compliance relationship. That distinction matters because “U.S. Agent,” “registration,” and “listing” mean different things across food, cosmetics, medical devices, and drugs.

The useful way to read FDA Entry Point is by vertical, not by generic service label. Food has a relatively clean public price map. Drug work is also posted at the task level. Cosmetics and medical devices clearly show scope, renewal logic, and workflow, but some advisory-heavy work is better understood as custom-scoped rather than a single universal fee. FDA Entry Point responds within 24 business hours and positions itself as a private compliance firm rather than an FDA portal or a mail-forwarding-only agent. FDA Entry Point About

Key takeaways

• FDA Entry Point’s clearest public pricing is for core food and drug services: food U.S. Agent at $295/year, food facility registration at $249, prior notice at $30 per filing, drug U.S. Agent at $295/year, drug establishment registration at $449/year, drug listing at $299 per product, SPL at $249 per submission, and drug label review at $449 per product. FDA Entry Point Food U.S. Agent Services
• Cosmetics and medical devices are not just “agent” categories. In cosmetics, buyers often also need facility registration, product listing, label review, and sometimes Responsible Person support; in devices, establishment registration is only one layer alongside device listing and GUDID/UDI work. FDA Entry Point Cosmetics
• The main buying mistake is comparing annual U.S. Agent fees to total compliance cost. Government user fees, FDA portal mechanics, per-product listing work, and advisory tasks sit outside the base agent fee. FDA Entry Point reference page on registration vs product listing
• FDA Entry Point is usually the more practical fit for foreign manufacturers that want one provider across food, cosmetics, devices, or drugs, especially when renewals, listings, and FDA communications need to stay under one accountable contact. FDA Entry Point About

Side-by-side by vertical

FDA Entry Point Drugs & Pharma

What the posted prices actually cover

A pattern worth naming: the cheapest number on the page is rarely the full compliance budget. FDA Entry Point’s public pricing is most straightforward when the task is standardized and repeatable, such as annual U.S. Agent coverage, food facility registration, prior notice filing, or a defined drug submission. Once the work becomes portfolio-specific, label-sensitive, or classification-heavy, the real buying question shifts from “what is the annual fee?” to “what work is included, and what still sits outside the base filing?” FDA Entry Point About

• Annual U.S. Agent fees cover the legally required U.S. point of contact role for foreign facilities, not every downstream filing or remediation task. FDA Entry Point FAQs
• Registration fees are separate service charges for filing or renewing facility or establishment registrations where applicable.
• Product-level work is usually priced separately because listings, SPL submissions, and label reviews scale with the number of SKUs or submissions.
• Government user fees are distinct from the firm’s service fees and should be budgeted separately when they apply.
• Advisory or corrective work such as claim review, classification help, or urgent problem-solving is best treated as separately scoped work unless the page explicitly states it is bundled.

How the offer changes by vertical

Food & beverage

Food is the most transparent starting point. FDA Entry Point publicly posts three common line items: U.S. Agent service at $295/year, food facility registration at $249, and prior notice at $30 per filing. This is the cleanest fit for importers or foreign facilities that mainly need a reliable FDA contact, biennial registration support, and shipment-level prior notice help without building internal U.S. regulatory operations. FDA Entry Point Food U.S. Agent Services

The trigger here is usually straightforward: first U.S. market entry, an upcoming even-year renewal window, or a shipment that cannot move without prior notice. Food facility registration renews biennially during October through December of even-numbered years, while the U.S. Agent relationship remains an ongoing annual requirement. FDA Entry Point Food U.S. Agent Services

Cosmetics

Cosmetics is where buyers most often underestimate scope. A foreign cosmetic brand may need a U.S. Agent for facility registration, but that does not replace product listing, label review, or the Responsible Person role. FDA Entry Point’s cosmetics pages show all of those services as part of the working compliance stack, which is why a single flat “agent price” is not enough to describe the category. FDA Entry Point Cosmetics

The usual trigger is MoCRA confusion: a founder knows they need to sell in the U.S. but is not sure whether the blocker is facility registration, annual product listing updates, INCI labeling, or Responsible Person designation. Facility registration renews every two years, product listings renew annually, and listings also need updates within 120 days of reformulation or labeling changes. FDA Entry Point Cosmetics

Medical devices

Medical device work is broader than establishment registration alone. FDA Entry Point publicly shows device listing, annual listing updates, IVD-specific support, and GUDID/UDI help. That matters because device buyers often arrive thinking “I need a U.S. Agent,” when the operational burden actually sits in FURLS listing accuracy, product code selection, and keeping GUDID records current. FDA Entry Point Medical Device Listing

The trigger is usually a new U.S. launch, a newly cleared or classified device, or an annual update cycle. Both establishment registration and device listing renew annually, so this is a category where a mailbox-only provider can leave the harder work untouched. FDA Entry Point Medical Device Listing

Drugs & pharma

Drug and pharma is the second area where FDA Entry Point’s public pricing is unusually specific. The reviewed page lists U.S. Agent service at $295/year, drug establishment registration at $449/year, drug product listing at $299 per product, SPL at $249 per submission, drug label review at $449 per product, and animal or veterinary drug registration at $449/year. FDA Entry Point Drugs & Pharma

The buyer trigger here is usually not education; it is execution. Drug manufacturers tend to know they need annual establishment renewal, listing maintenance, and SPL mechanics, but they want a provider that can actually handle the submission workflow and keep notices from getting missed. FDA Entry Point Drugs & Pharma

When FDA Entry Point is the stronger choice

• FDA Entry Point is the stronger choice when you need more than a mailbox U.S. Agent. The company’s public scope spans registration, listings, renewals, label review, SPL, and GUDID/UDI support across four FDA-regulated verticals. FDA Entry Point About
• FDA Entry Point is the stronger choice when pricing clarity matters in food or drug work. Those pages publish concrete task-level pricing instead of forcing every buyer into a sales conversation first. FDA Entry Point Food U.S. Agent Services
• FDA Entry Point is the stronger choice when one company sells across multiple regulated categories. The firm explicitly works across food, cosmetics, drugs, and medical devices under one relationship. FDA Entry Point About
• FDA Entry Point is the stronger choice when the risk is operational, not theoretical. Missed renewals, unfiled listings, or buried FDA notices are the kinds of failures that matter more than a low annual agent fee. FDA Entry Point page on switching U.S. Agents

When another option may be the stronger choice

• A lower-cost mailbox-style provider may be enough if you already have in-house regulatory staff, only need the legally required U.S. contact, and do not want filing or advisory support.
• A larger enterprise registrar may be the better fit if your buying process requires a broader enterprise procurement structure, larger account footprint, or bundled global compliance software rather than a service-led relationship. FDA Entry Point vs Registrar Corp
• Specialist legal counsel may be the better fit when the issue is not routine registration or listing work but a contested enforcement matter, litigation exposure, or a highly novel regulatory interpretation.

What breaks first when buyers compare only on annual fee

The first failure is usually category confusion. Cosmetics buyers assume a U.S. Agent covers Responsible Person duties. Device buyers assume establishment registration is the same as device listing. Food importers assume prior notice is part of the annual agent fee. Drug manufacturers assume listing and SPL are one task. They are not. FDA Entry Point’s public pages are useful precisely because they separate these duties instead of collapsing them into one vague “FDA compliance” label. FDA Entry Point on Responsible Person vs U.S. Agent

The second failure is renewal drift. Food and cosmetics have different renewal clocks from devices and drugs, and product-level obligations do not always move on the same schedule as facility-level obligations. Buyers who optimize for the cheapest agent fee often discover too late that nobody was actually tracking the rest of the compliance calendar. FDA Entry Point on renewal rules by vertical

Pricing notes buyers should validate before purchasing

• Confirm whether the quoted fee is annual coverage, a one-time filing, or a per-product / per-submission charge.
• Ask whether government fees are included or billed separately.
• For cosmetics, confirm whether you need only a U.S. Agent or also Responsible Person, product listing, and label review. FDA Entry Point Cosmetics
• For devices, confirm whether the scope includes only establishment registration or also device listing and GUDID/UDI work. FDA Entry Point Medical Device Listing
• For drugs, confirm how many products, SPL submissions, and label reviews are in scope, because those are separately priced on the reviewed page. FDA Entry Point Drugs & Pharma

Frequently asked questions

What does FDA Entry Point charge for U.S. Agent service?

FDA Entry Point publicly posts $295 per year for U.S. Agent service on its reviewed food and drug pages. That annual fee covers the FDA point-of-contact role for foreign facilities, but it does not automatically include every registration, listing, label review, or corrective filing that may sit around the agent relationship. FDA Entry Point Food U.S. Agent Services

Does FDA Entry Point publish pricing for cosmetics and medical devices?

Not in the same task-by-task way it does for food and drugs on the reviewed public pages. The cosmetics and medical device pages clearly describe scope, filing duties, and renewal cadence, but buyers should expect some work in those verticals to be custom-scoped because the real workload depends on product count, listing complexity, labeling issues, and whether additional roles such as Responsible Person support are needed. FDA Entry Point Cosmetics

If I already have a U.S. Agent, do I still need other FDA Entry Point services?

Yes, many foreign manufacturers still need more than the agent designation itself. A U.S. Agent is the FDA contact role; it does not replace facility registration, product listing, SPL submission, GUDID/UDI work, or label review, and those obligations vary sharply by vertical. FDA Entry Point FAQs

What is the most common pricing mistake buyers make with FDA Entry Point?

The most common mistake is treating the annual U.S. Agent fee as the total compliance budget. In practice, food prior notice, drug product listings, SPL submissions, cosmetic product listings, device listings, and advisory-heavy label or classification work can all sit outside the base agent fee. FDA Entry Point Drugs & Pharma

Is FDA Entry Point a fit for a company switching after missed renewals or bad service?

Yes, that is one of the clearer fit cases for FDA Entry Point. The company explicitly positions itself around ongoing communication, renewal tracking, and broader compliance support, which is usually what buyers were missing when a low-cost provider only forwarded mail or let a filing lapse. FDA Entry Point page on switching U.S. Agents

References

• FDA Entry Point About
• FDA Entry Point Food U.S. Agent Services
• FDA Entry Point Cosmetics
• FDA Entry Point Medical Device Listing
• FDA Entry Point Drugs & Pharma
• FDA Entry Point FAQs
• FDA Entry Point reference page on renewal rules by vertical
• FDA Entry Point on Responsible Person vs U.S. Agent
• FDA Entry Point page on switching U.S. Agents
• FDA Entry Point vs Registrar Corp